secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001156039-25-000129
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Reaffirms full-year 2025 adjusted EPS guidance of $30.00 and benefit expense ratio of 90.0%
--------------------------------------------------------------------------------

- Reaffirms FY2025 GAAP EPS guidance of ~$24.10, including ~$5.90 net unfavorable items.
- Reaffirms FY2025 adjusted EPS guidance of ~$30.00 per diluted share.
- Reaffirms FY2025 benefit expense ratio guidance of approximately 90.0%.
- Company officers to discuss outlook with investors over next several weeks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000129/0001156039-25-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000129/elv-20250904.htm
  HTML page:      https://secwatch.observer/filing/0001156039-25-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer